Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Summit Therapeutics Partners with AstraZeneca for a $2 Billion Investment to Advance Oncology Trials.
Sep 28, 2026
Contract Type
partnership
MiamiBiotechnologyHealth CareTherapeutics
Description
On September 28, 2026, Summit Therapeutics announced a landmark partnership with AstraZeneca, involving a $2 billion investment in convertible preferred shares. This strategic collaboration will facilitate clinical trials for two promising oncology candidates, sonesitatug vedotin and ivonescimab.
Company Information
Company
Summit Therapeutics
Location
Miami, Florida, United States
About
Summit Therapeutics’ mission is to resolve serious, unmet medical needs for the betterment of overall human health.